The effect of colloid formulation on colloid osmotic pressure in horses with naturally occurring gastrointestinal disease.
Authors: Bellezzo Fausto, Kuhnmuench Timothy, Hackett Eileen S
Journal: BMC veterinary research
Summary
# Editorial Summary Acute gastrointestinal disease frequently causes severe protein loss in horses, necessitating fluid support with colloid solutions to maintain circulating volume and colloid osmotic pressure (COP)—the force that keeps fluid in the vasculature. This 2014 study compared two formulations of high molecular weight hydroxyethyl starch colloids in naturally affected horses, evaluating their effectiveness at sustaining COP alongside acid-base balance and clinical outcomes. The researchers administered different starch preparations to hypoprotaemic horses with GI disease, measuring changes in plasma osmotic pressure, blood gas parameters, and survival rates between treatment groups. Understanding which colloid formulation most effectively maintains COP over time is crucial for practitioners managing the haemodynamic instability that accompanies conditions such as severe colitis or small intestinal disease. Results from this work should inform fluid therapy protocols in equine practice, particularly when selecting between available colloid products for cases where maintaining oncotic pressure is essential to preventing further tissue oedema and supporting organ perfusion during the critical early stages of GI disease management.
Read the full abstract on PubMed
Practical Takeaways
- •When selecting colloid fluid therapy for hypoprotemic horses with GI disease, compare HES formulation options for their specific effects on maintaining colloid osmotic pressure and acid-base status
- •Understanding colloid formulation differences helps optimize supportive care protocols in acute GI disease cases where plasma volume and protein support are critical
Key Findings
- •Two formulations of hydroxyethyl starch colloid were compared for their effects on colloid osmotic pressure in horses with naturally occurring GI disease and hypoproteinemia
- •Study evaluated the relative efficacy of high molecular weight HES formulations on COP maintenance, acid-base balance, and patient survival outcomes